News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Houman Sotoudeh: MRI Math, AI Platform-Cyber Device for GBM is now FDA-approved
Photo taken from Houman Sotoudeh/X
Aug 20, 2024, 10:46

Houman Sotoudeh: MRI Math, AI Platform-Cyber Device for GBM is now FDA-approved

Houman Sotoudeh, Associate Professor of Neuroradiology and Neurology at University of Alabama at Birmingham, shared on X:

“I’m thrilled to share that the AI Platform-Cyber Device for glioblastoma multiforme (GBM), which I had the privilege of helping to develop, is now FDA-approved and commercially available!”

Additional information.
Source: Houman Sotoudeh/X

AI cancer FDA GBM glioblastoma multiforme Houman Sotoudeh MRI Math OncoDaily Oncology University of Alabama at Birmingham
Special Coverage
Science
Jan 15, 2025, 14:03
A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors
Blog
Jan 15, 2025, 14:02
Ahmed Kotb has joined Daiichi Sankyo as the Head of Global Oncology Medical Affairs
Science
Jan 15, 2025, 14:01
Kai Rejeski: Delineating the prognostic significance of immune reconstitution in CAR-T recipients
Blog
Jan 15, 2025, 13:58
Priscilla Chan: Big ideas need big tools
Blog
Jan 15, 2025, 13:54
FDA Fast Tracks Emiltatug Ledadotin in Advanced or Metastatic Breast Cancer
Insight
Jan 15, 2025, 13:50
Senthil Kumar: Systemic Treatment for Advanced/Metastatic Synovial Sarcoma
Blog
Jan 15, 2025, 13:48
Rahul Banerjee: My takeaways from RedirecTT-1 for Fred Hutchinson Cancer Center journal watch
Opinion
Jan 15, 2025, 13:47
5 Articles suggested by Wafik El-Deiry
Dialogues
Jan 15, 2025, 13:46
Global Equity of Clinical Trials - Global Cancer Movement
Blog
Jan 15, 2025, 13:45
Laura Alder: Honored, thankful, and excited to be a part of the 2025 IASLC Academy
Science
Jan 15, 2025, 13:40
Final Overall Survival in the Phase III FALCON Trial by John Robertson et al.
Blog
Jan 15, 2025, 13:35
Wafik S. El-Deiry: TRAIL agonists rescue mice from radiation-induced lung, skin or esophageal injury